相关实验视频

Updated: May 12, 2025

A Neurosphere Assay to Evaluate Endogenous Neural Stem Cell Activation in a Mouse Model of Minimal Spinal Cord Injury

A Neurosphere Assay to Evaluate Endogenous Neural Stem Cell Activation in a Mouse Model of Minimal Spinal Cord Injury

Published on: September 13, 2018

在脊髓损伤中,来自各种细胞源的外体的作用

Wangnan Mao¹, Xinghao Liu¹, Chen Chen²

¹The Second Clinical College, Zhejiang Chinese Medical University, Hangzhou, China.

Molecular neurobiology

|May 10, 2025

概括

外体细胞通过输送治疗分子显示出对脊髓损伤 (SCI) 修复的希望. 本研究根据来源对外体进行分类,并探索工程外体,以提高SCI治疗策略.

科学领域:

再生医学是一种再生医学.
神经科学是一个神经科学.
生物技术是生物技术.

背景情况:

脊髓损伤 (SCI) 在中枢神经系统 (CNS) 中存在重大再生挑战,导致永久性功能缺陷.
目前的SCI治疗方法有限,需要探索新的治疗策略.
外体,纳米级囊泡,由于它们的载荷传递能力和低免疫性,正在成为强大的治疗剂.

研究的目的:

根据SCI治疗的供体细胞特征对外体进行分类.
审查目前的研究和基于外体的SCI治疗的未来方向.
研究工程外体的应用与SCI修复的先进治疗策略相结合.

主要方法:

从介质细胞干细胞,神经细胞,免疫细胞和血管相关细胞分类出外体.
对每个外体源进行研究进展和未来方向的深入审查.
工程外体应用的分析,包括药物输送,表面工程和组织工程集成.

主要成果:

外体体表现出各种治疗作用,包括抗炎,抗亡,自,血管,神经和轴突重塑活动.
分类提供了一个框架,以了解不同细胞起源的外体潜力.
工程外生体表现出药物输送能力的增强以及与其他再生策略的协同效应.

结论:

外体代表了一种有前途的无细胞治疗方法,用于脊髓损伤 (SCI) 修复.
定制外体源和工程策略可以优化治疗结果.
对临床应用的进一步研究是有必要的,以克服基于外体的SCI治疗的现有挑战.

关键词:

细胞来源细胞来源外基因组是外基因组的组成部分.脊髓损伤导致的脊髓损伤治疗方法治疗方法

更多相关视频

Synergetic Use of Neural Precursor Cells and Self-assembling Peptides in Experimental Cervical Spinal Cord Injury

Synergetic Use of Neural Precursor Cells and Self-assembling Peptides in Experimental Cervical Spinal Cord Injury

Published on: February 23, 2015

Author Spotlight: Long-Term Spinal Cord Slice Culture for Advancing Spinal Cord Regeneration Therapies

Author Spotlight: Long-Term Spinal Cord Slice Culture for Advancing Spinal Cord Regeneration Therapies

Published on: April 12, 2024

相关概念视频

Overview of Exosomes

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...

Mesenchymal Stem Cells

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...

Clinical Applications of Epidermal Stem Cells

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...

Neurogenesis and Regeneration of Nervous Tissue

Neurogenesis and Regeneration of Nervous Tissue

In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...